Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer (Q81430199)
Jump to navigation
Jump to search
scientific article published on 22 February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer |
scientific article published on 22 February 2005 |
Statements
Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer (English)
Susan F Slovin
Govind Ragupathi
Cristina Musselli
Celina Fernandez
Meghan Diani
David Verbel
Samuel Danishefsky
Philip Livingston
Howard I Scher
22 February 2005